Robert R. Jenq

6 ta ish

The University of Texas MD Anderson Cancer Center

1. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

   Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67

   Maqola20177 iqtibos

   ABIABI:AkademIndex/2026.other.339918

2. Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease

   Nathan D. Mathewson, Robert R. Jenq, Anna V. Mathew +18

   MaqolaOAOchiq kirish20164 iqtibos

   ABIABI:AkademIndex/2026.other.042723

3. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation

   Ying Taur, Robert R. Jenq, Miguel‐Angel Perales +12

   Maqola20143 iqtibos

   ABIABI:AkademIndex/2026.other.480480

4. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

   Christine N. Spencer, Jennifer L. McQuade, Vancheswaran Gopalakrishnan +86

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.468922

5. <i>Lactobacillus rhamnosus GG</i> probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation

   Elan Gorshein, Catherine Wei, Susan Ambrosy +13

   Maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.480495

6. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

   Jonathan U. Peled, Antonio L. C. Gomes, Sean M. Devlin +49

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.480509